A panel of experts on chronic myeloid leukemia discuss common patient concerns, adverse effect considerations, and best practices for setting clear expectations.
This program was made possible with support from Novartis Pharmaceuticals.
Video content above is prompted by the following questions:
View additional resources on CureToday.com